Collaboration harnesses enzymes to enhance nutrition

By Peter Kent

Merging the benefits of diet with pharmaceuticals and genomics has created a rapidly growing global business in nutrition. Clemson is taking the lead to expand South Carolina’s economy in this expanding industry.

Clemson has formed a partnership with Diversa Corporation of San Diego, CA, to develop enzymes with the potential to enhance human nutrition. Researchers will initially evaluate the ability of adding protein supplements to food to improve stamina and alertness and reduce fatigue.

“Diversa’s strengths in discovering and optimizing novel proteins are highly complementary to Clemson’s research capabilities to rapidly test and develop new nutraceutical compounds,” said David Gangemi, director of Clemson’s Institute of Nutraceutical Research.

Jay M. Short, president of Diversa, said, “Clemson University and the Institute of Nutraceutical Research have developed impressive capabilities to accelerate the practical deployment of new technology aimed at improving human nutrition. The institute’s ability to organize and run clinical testing programs and their established packaging and formulation expertise will help bring novel protein solutions to the consumer in a rapid, effective, safe and economical process.

Karl Kelly, CEO of SC Bio, the state’s biotechnology incubator, said, “We believe this type of alliance will be pivotal in advancing research and creating new commercial avenues for South Carolina technologies.”




For information: David Gangemi, 864-656-6463, gangemj@clemson.edu